Last reviewed · How we verify
VI-0521 Mid Dose
VI-0521 Mid Dose is a Small molecule drug developed by VIVUS LLC. It is currently FDA-approved. Also known as: Phentermine/Topiramate.
VI-0521 is being studied as a potential treatment for obesity, type 2 diabetes, and related conditions in adults and children. In a Phase III clinical trial, VI-0521 was compared to placebo and its single-agent constituents, including topiramate and phentermine, for the treatment of obesity in adults.
At a glance
| Generic name | VI-0521 Mid Dose |
|---|---|
| Also known as | Phentermine/Topiramate |
| Sponsor | VIVUS LLC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity (PHASE4)
- A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents (PHASE4)
- A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults (PHASE3)
- Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VI-0521 Mid Dose CI brief — competitive landscape report
- VI-0521 Mid Dose updates RSS · CI watch RSS
- VIVUS LLC portfolio CI
Frequently asked questions about VI-0521 Mid Dose
What is VI-0521 Mid Dose?
Who makes VI-0521 Mid Dose?
Is VI-0521 Mid Dose also known as anything else?
What development phase is VI-0521 Mid Dose in?
Related
- Manufacturer: VIVUS LLC — full pipeline
- Also known as: Phentermine/Topiramate
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing